EFFECT OF L-DOPA, OXYFERRISCORBONE AND FERROUS IRON ON INVIVO LIPID-PEROXIDATION

被引:7
作者
DOSTERT, P
BENEDETTI, MS
FRIGERIO, E
机构
[1] Research and Development - Erbamont Group, Farmitalia Carlo Erba, Milan
关键词
L-DOPA; FERROUS IRON; LIPID PEROXIDATION; PARKINSONS DISEASE; OXYFERRISCORBONE;
D O I
10.1007/BF01249115
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We report here on an in vivo model of lipid peroxidation, which consists in measuring the amount of ethane present in the exhaled air after the oral administration of linolenic acid to rats. This model was used to study the effect of L-dopa, oxyferriscorbone (OFS), a ferri-ferro-complex, and ferrous iron, this latter alone or associated with ascorbic acid, on lipid peroxidation. Intravenous or oral administration of L-dopa did not influence the amount of ethane produced by an oral dose of 1.25 ml/kg of linolenic acid. Intravenous injection of OFS (50 mg/kg) as well as the co-injection of FeSO4, 7H2O (15 mg/kg) and ascorbic acid (15 mg/kg) were found to decrease the amount of ethane produced by 1.25 ml/kg of linolenic acid given orally, whereas the same dose of ferrous sulfate alone was ineffective. The possible causes which might underlie the absence of effects of L-dopa and ferrous iron and the partial inhibition of lipid peroxidation by OFS and ferrous ions associated with ascorbic acid are discussed.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 31 条
[1]  
BENEDETTI MS, 1989, NEW DIRECTIONS AFFEC, P156
[2]   IRON, A NEW AID IN THE TREATMENT OF PARKINSON PATIENTS [J].
BIRKMAYER, W ;
BIRKMAYER, JGD .
JOURNAL OF NEURAL TRANSMISSION, 1986, 67 (3-4) :287-292
[3]  
BIRKMAYER W, 1988, PROGR CATECHOLAMIN C, P25
[4]   EXHALED ALKANES AS INDEXES OF INVIVO LIPID-PEROXIDATION [J].
BURK, RF ;
LUDDEN, TM .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (07) :1029-1032
[5]  
Cohen G, 1983, J Neural Transm Suppl, V19, P89
[6]   DEPRENYL SUPPRESSES THE OXIDANT STRESS ASSOCIATED WITH INCREASED DOPAMINE TURNOVER [J].
COHEN, G ;
SPINA, MB .
ANNALS OF NEUROLOGY, 1989, 26 (05) :689-690
[7]  
DEXTER D, 1986, LANCET, V2, P639
[8]   INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
WELLS, FR ;
LEES, AJ ;
AGID, F ;
AGID, Y ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1830-1836
[9]   BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
CARTER, CJ ;
WELLS, FR ;
JAVOYAGID, F ;
AGID, Y ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389
[10]  
DORDAIN G, 1988, NEW TRENDS CLIN NEUR, V2, P152